Investigating gene promoter methylation in a mouse model of status epilepticus

Methods in Molecular Biology

Volumn 1067, Issue , 2013, Pages 87-101

  Miller Delaney, Suzanne F C ^a   Das, Sudipto ^a,b   Stallings, Raymond L ^a,b   Henshall, David C ^a  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^b OUR LADY S CHILDREN S HOSPITAL   (Ireland)

Author keywords

DNA methylation; Epigenetics; Methylated DNA immunoprecipitation (MeDIP); Promoter methylation; Status epilepticus

Indexed keywords

BISULFITE; DNA; LORAZEPAM;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DNA METHYLATION; DNA SEQUENCE; EPILEPTIC STATE; GENOME; HIPPOCAMPUS; IMMUNOPRECIPITATION; METHYLATED DNA IMMUNOPRECIPITATION; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; SEIZURE;

ANIMALS; DISEASE MODELS, ANIMAL; DNA; DNA METHYLATION; IMMUNOPRECIPITATION; MICE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROMOTER REGIONS, GENETIC; STATUS EPILEPTICUS; SULFITES;

EID: 84884176211     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-607-8_7     Document Type: Article

References (24)

1. Feng J, Fan G (2009) The role of DNA methylation in the central nervous system and neuropsychiatric disorders. Int Rev Neurobiol 89: 67-84
2. Robertson KD (2005) DNA methylation and human disease. Nat Rev Genet 6: 597-610
3. Jaenisch R, Bird A (2003) Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 33(Suppl): 245-254
4. Iraola-Guzman S, Estivill X, Rabionet R (2011) DNA methylation in neurodegenerative disorders: a missing link between genome and environment? Clin Genet 80: 1-14
5. Miller CA, Sweatt JD (2007) Covalent modification of DNA regulates memory formation. Neuron 53: 857-869
6. Miller-Delaney SF, Das S, Sano T, Jimenez-Mateos EM, Bryan K, Buckley PG et al (2012) Differential DNA methylation patterns define status epilepticus and epileptic tolerance. J Neurosci 32: 1577-1588
7. Urdinguio RG, Sanchez-Mut JV, Esteller M (2009) Epigenetic mechanisms in neurological diseases: genes, syndromes, and therapies. Lancet Neurol 8: 1056-1072
8. Guo JU, Ma DK, Mo H, Ball MP, Jang MH, Bonaguidi MA et al (2011) Neuronal activity modifies the DNA methylation landscape in the adult brain. Nat Neurosci 14: 1345-1351
9. Levenson JM, Roth TL, Lubin FD, Miller CA, Huang IC, Desai P et al (2006) Evidence that DNA (cytosine-5) methyltransferase regulates synaptic plasticity in the hippocampus. J Biol Chem 281: 15763-15773
10. Zhu Q, Wang L, Zhang Y, Zhao FH, Luo J, Xiao Z et al (2012) Increased expression of DNA methyltransferase 1 and 3a in human temporal lobe epilepsy. J Mol Neurosci 46: 420-426
11. Kobow K, Jeske I, Hildebrandt M, Hauke J, Hahnen E, Buslei R et al (2009) Increased reelin promoter methylation is associated with granule cell dispersion in human temporal lobe epilepsy. J Neuropathol Exp Neurol 68: 356-364
12. Aminoff MJ, Simon RP (1980) Status epilepticus. Causes, clinical features and consequences in 98 patients. Am J Med 69: 657-666
13. Fujikawa DG, Itabashi HH, Wu A, Shinmei SS (2000) Status epilepticus-induced neuronal loss in humans without systemic complications or epilepsy. Epilepsia 41: 981-991
14. Hatazaki S, Bellver-Estelles C, Jimenez-Mateos EM, Meller R, Bonner C, Murphy N et al (2007) Microarray profile of seizure damage-refractory hippocampal CA3 in a mouse model of epileptic preconditioning. Neuroscience 150: 467-477
15. Jimenez-Mateos EM, Hatazaki S, Johnson MB, Bellver-Estelles C, Mouri G, Bonner C et al (2008) Hippocampal transcriptome after status epilepticus in mice rendered seizure damage-tolerant by epileptic preconditioning features suppressed calcium and neuronal excitability pathways. Neurobiol Dis 32: 442-453
16. Jimenez-Mateos EM, Henshall DC (2009) Seizure preconditioning and epileptic tolerance: models and mechanisms. Int J Physiol Pathophysiol Pharmacol 1: 180-191
17. Jimenez-Mateos EM, Mouri G, Conroy RM, Henshall DC (2010) Epileptic tolerance is associated with enduring neuroprotection and uncoupling of the relationship between CA3 damage, neuropeptide Y rearrangement and spontaneous seizures following intra-amygdala kainic acid-induced status epilepticus in mice. Neuroscience 171: 556-565
18. Jimenez-Mateos EM, Engel T, Merino-Serrais P, McKiernan RC, Tanaka K, Mouri G et al (2012) Silencing microRNA-134 produces neuroprotective and prolonged seizuresuppressive effects. Nat Med 18: 1087-1094
19. Weber M, Davies JJ, Wittig D, Oakeley EJ, Haase M, Lam WL, Schubeler D (2005) Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells. Nat Genet 37: 853-862
20. Buckley PG, Das S, Bryan K, Watters KM, Alcock L, Koster J et al (2011) Genome-wide DNA methylation analysis of neuroblastic tumors reveals clinically relevant epigenetic events and large-scale epigenomic alterations localized to telomeric regions. Int J Cancer 128: 2296-2305
21. Das S, Bryan K, Buckley PG, Piskareva O, Bray IM, Foley N et al (2013) Modulation of neuroblastoma disease pathogenesis by an extensive network of epigenetically regulated microRNAs. Oncogene 32(24): 2927-2936
22. Das S, Foley N, Bryan K, Watters KM, Bray I, Murphy DM et al (2010) MicroRNA mediates DNA demethylation events triggered by retinoic acid during neuroblastoma cell differentiation. Cancer Res 70: 7874-7881
23. Paxinos G, Franklin KBJ (1997) The mouse brain in stereotaxic coordinates. Academic, San Diego, CA
24. Lein ES, Zhao X, Gage FH (2004) Defining a molecular atlas of the hippocampus using DNA microarrays and highthroughput in situ hybridization. J Neurosci 24: 3879-3889